Centessa Pharmaceuticals plc (CNTA)

NASDAQ: CNTA · Real-Time Price · USD

39.60

-0.07 (-0.18%)

At close: May 6, 2026, 4:00 PM EDT

40.46

+0.85 (2.16%)

After-hours: May 6, 2026, 7:26 PM EDT

Centessa Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2020
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '20 Dec 31, 2020
Revenue	-	15	-	6.85	-	-
Gross Profit	-	15	-	6.85	-	-
Selling, General & Admin	58.02	50.47	50.81	53.73	55.2	1.14
Research & Development	198.67	172.22	150.24	124.41	155.08	9.3
Other Operating Expenses	-	-	-	-	1.98	-
Total Operating Expenses	256.69	222.69	201.06	178.14	212.26	10.44
Operating Income	-256.69	-207.69	-201.06	-171.28	-212.26	-10.44
Interest Income	17.78	20.53	14.02	10.48	0.24	-
Interest Expense	-11.31	-11.46	-10.09	-9.91	-7.28	-0.31
Other Non-Operating Income (Expense)	0.86	2.91	-35.78	-5.43	2.34	0.09
Total Non-Operating Income (Expense)	7.32	11.98	-31.86	-4.86	-4.69	-0.22
Pretax Income	-249.37	-195.71	-232.91	-176.14	-216.95	-10.66
Provision for Income Taxes	1.27	1.82	2.84	-25.06	-0.75	-
Net Income	-250.64	-197.53	-235.76	-151.09	-216.21	-10.66
Net Income to Common	-250.64	-197.53	-235.76	-151.09	-216.21	-10.66
Shares Outstanding (Basic)	141	136	114	96	93	4
Shares Outstanding (Diluted)	141	136	114	96	93	4
Shares Change (YoY)	14.78%	18.56%	19.02%	2.97%	2283.79%	-
EPS (Basic)	-1.79	-1.46	-2.06	-1.57	-2.31	-0.80
EPS (Diluted)	-1.79	-1.46	-2.06	-1.57	-2.31	-0.80
Shares Outstanding	154.73	149.23	132.63	96.18	94.84	7.5
Free Cash Flow	-209.1	-194.19	-142.09	-160.51	-201.68	-10.63
Free Cash Flow Per Share	-1.48	-1.43	-1.24	-1.67	-2.16	-2.71
Gross Margin	-	100.00%	-	100.00%	-	-
Operating Margin	-	-1384.61%	-	-2499.39%	-	-
Profit Margin	-	-1316.88%	-	-2204.65%	-	-
FCF Margin	-	-1294.59%	-	-2342.20%	-	-
EBITDA	-255.75	-206.77	-200.11	-170.47	-212.13	-10.44
EBITDA Margin	-	-1378.47%	-	-2487.57%	-	-
EBIT	-256.69	-207.69	-201.06	-171.28	-212.26	-10.44
EBIT Margin	-	-1384.61%	-	-2499.39%	-	-
Effective Tax Rate	-0.51%	-0.93%	-1.22%	14.22%	0.34%	0.00%

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q